GLAXOSMITHKLINE

That this House congratulates the US Department of Justice for again successfully prosecuting GlaxoSmithKline (GSK) for tricking and bribing doctors into prescribing children with dangerous anti-depressants, hiding scientific evidence, manipulating articles in medical journals and lavishing bribes on doctors; notes that this deplorable conduct fatally harmed patient health, cheated taxpayers and violated public trust; and calls for the prosecution of GSK in the UK where similar abuses occurred.